Skip to content
Lower risk Medical device recall · FDA · Published January 20, 2021

R&D Systems Quantikine sTfR ELISA Kit Recall: Low Signal and Control Issues

R&D Systems recalls Quantikine Human sTf:R ELISA Kit due to low signal and out-of-specification controls. Affected kits may not provide accurate anemia/polycythemia test results.

🇺🇸 FDA recall #Z-1255-2021Medical deviceR&D Systems ›
Take action

Contact the company

Recalling firmR & D Systems, Inc.614 Mckinley Pl Ne · Minneapolis, MN 55413-2610
✎ GovInfoNow plain-language explainer

R&D Systems is recalling Quantikine Human sTfR ELISA Kits because they produce low signal and out-of-specification controls, which could lead to inaccurate anemia or polycythemia test results. This affects kits with specific lot numbers and catalog codes. Read more at govinfonow.com/recall/63361-r-d-systems-quantikine-stfr-elisa-kit-recall-low-signal.

Source Summary by GovInfoNow · govinfonow.com/recall/63361-r-d-systems-quantikine-stfr-elisa-kit-recall-low-signal · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1255-2021

Cite this page

“R&D Systems Quantikine sTfR ELISA Kit Recall: Low Signal and Control Issues.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63361-r-d-systems-quantikine-stfr-elisa-kit-recall-low-signal. Based on FDA recall #Z-1255-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1255-2021%22&limit=1).

The FDA announced on Jan. 20, 2021, that R & D Systems, Inc. is recalling Quantikine IVD Human sTfR Immunoassay kits due to low standard signals and out-of-specification controls. The agency issued recall number Z-1255-2021 for the voluntary Class II recall.

How to tell if you have it

  • Brand: R&D Systems
  • Product: Quantikine IVD Human sTfR Immunoassay (Human sTransferrin ELISA Kit)
  • Catalog #: DTFR1
  • Lot codes: P252478, P263156, P256349, P263160, P264604
  • Units affected: 156 kits

The hazard

R&D Systems received two complaints that the standard signal was low and controls were not within the specification range. An investigation confirmed low standard signals and controls running out of specification for returned and retained kits.

Context

GovInfoNow's records show R & D Systems, Inc. has had four other recalls since Sept. 11, 2018, including a Nov. 7, 2022, recall for microbial contamination risk in CBC-3D Hematology Controls and a June 14, 2022, recall for CE marking errors. Other recent recalls of similar products include the Immunotech Estrone RIA Kit (Dec. 15, 2025), Stago STA Liatest Free Protein S (Feb. 4, 2026), and Roche Elecsys Anti-TSHR Assay (Nov. 21, 2025).

How to tell if you have this one

Check for the catalog number DTFR1 and lot numbers P252478, P263156, P256349, P263160, or P264604. The kit is sold as an enzyme-linked immunosorbent assay for human serum and plasma testing.

  • Brand
    R&D Systems
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Lot Numbers

    Verify if your kit has lot numbers P252478, P263156, P256349, P263160, or P264604.

Where it went and when

Where it was distributed

Distributed in 4 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: yesLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: yesFL

FDA distribution: “USA: (FL, LA, CA, OH), CHINA, UNITED KINGDOM, JAPAN, SINGAPORE, Jakarta Selatan,” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Florida, Louisiana, Ohio.

Recall timeline

FDA terminated this recall 2.1 years after the firm started it.

1. Firm started the recall: Jan 20, 202112. FDA classified it Class II: Mar 15, 202123. Published in FDA’s Enforcement Report: Mar 24, 202134. FDA terminated the recall: Feb 13, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1255-2021 (January 20, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1255-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA